• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从竞争实验中获得的G蛋白偶联受体同源二聚体的有用药理学参数。激动剂-拮抗剂结合调节。

Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation.

作者信息

Casadó Vicent, Ferrada Carla, Bonaventura Jordi, Gracia Eduard, Mallol Josefa, Canela Enric I, Lluís Carmen, Cortés Antoni, Franco Rafael

机构信息

Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Department of Biochemistry and Molecular Biology, Faculty of Biology, University of Barcelona, Avda. Diagonal 465, 08028 Barcelona, Spain.

出版信息

Biochem Pharmacol. 2009 Dec 15;78(12):1456-63. doi: 10.1016/j.bcp.2009.07.012. Epub 2009 Jul 28.

DOI:10.1016/j.bcp.2009.07.012
PMID:19643089
Abstract

Many G-protein-coupled receptors (GPCRs) are expressed on the plasma membrane as dimers. Since drug binding data are currently fitted using equations developed for monomeric receptors, the interpretation of the pharmacological data are equivocal in many cases. As reported here, GPCR dimer models account for changes in competition curve shape as a function of the radioligand concentration used, something that cannot be explained by monomeric receptor models. Macroscopic equilibrium dissociation constants for the agonist and homotropic cooperativity index reflecting the intramolecular communication within the dopamine D1 or adenosine A2A receptor homodimer as well as hybrid equilibrium dissociation constant, which reflects the antagonist/agonist modulation may be calculated by fitting binding data from antagonist/agonist competition experiments to equations developed from dimer receptor models. Comparing fitting the data by assuming a classical monomeric receptor model or a dimer model, it is shown that dimer receptor models provide more clues useful in drug discovery than monomer-based models.

摘要

许多G蛋白偶联受体(GPCR)以二聚体形式表达于质膜上。由于目前药物结合数据是使用针对单体受体开发的方程进行拟合的,因此在许多情况下,药理学数据的解释并不明确。如本文所报道,GPCR二聚体模型解释了竞争曲线形状随所用放射性配体浓度的变化,而这是单体受体模型无法解释的。通过将拮抗剂/激动剂竞争实验的结合数据拟合到从二聚体受体模型开发的方程中,可以计算出激动剂的宏观平衡解离常数、反映多巴胺D1或腺苷A2A受体同二聚体内分子间通讯的同促协同指数,以及反映拮抗剂/激动剂调节作用的杂交平衡解离常数。通过比较假设经典单体受体模型或二聚体模型来拟合数据,结果表明二聚体受体模型比基于单体的模型能为药物发现提供更多有用线索。

相似文献

1
Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation.从竞争实验中获得的G蛋白偶联受体同源二聚体的有用药理学参数。激动剂-拮抗剂结合调节。
Biochem Pharmacol. 2009 Dec 15;78(12):1456-63. doi: 10.1016/j.bcp.2009.07.012. Epub 2009 Jul 28.
2
The two-state dimer receptor model: a general model for receptor dimers.双态二聚体受体模型:受体二聚体的通用模型。
Mol Pharmacol. 2006 Jun;69(6):1905-12. doi: 10.1124/mol.105.020685. Epub 2006 Feb 24.
3
Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.重新解释 G 蛋白偶联受体同源二聚体中异常竞争结合实验,使用二聚体受体模型。
Pharmacol Res. 2019 Jan;139:337-347. doi: 10.1016/j.phrs.2018.11.032. Epub 2018 Nov 22.
4
Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index.计算激动剂和拮抗剂与G蛋白偶联单体和二聚体受体相互作用亲和力的新旧方法:受体二聚体协同指数
Pharmacol Ther. 2007 Dec;116(3):343-54. doi: 10.1016/j.pharmthera.2007.05.010. Epub 2007 Jun 14.
5
Kinetic and functional properties of [3H]ZM241385, a high affinity antagonist for adenosine A2A receptors.腺苷A2A受体高亲和力拮抗剂[3H]ZM241385的动力学和功能特性
Life Sci. 2005 Feb 11;76(13):1513-26. doi: 10.1016/j.lfs.2004.10.027. Epub 2004 Dec 19.
6
Enhancer and competitive allosteric modulation model for G-protein-coupled receptors.G 蛋白偶联受体的增强子和竞争性变构调节模型。
J Theor Biol. 2010 Dec 21;267(4):663-75. doi: 10.1016/j.jtbi.2010.08.024. Epub 2010 Aug 26.
7
Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.双相情感障碍患者在接受典型抗精神病药物治疗时,其血小板中A2A腺苷受体上调。
J Psychiatr Res. 2006 Feb;40(1):81-8. doi: 10.1016/j.jpsychires.2004.12.008.
8
Characterization of [125I]ZM 241385 binding to adenosine A2A receptors in the pineal of sheep brain.绵羊脑松果体中[125I]ZM 241385与腺苷A2A受体结合的特性研究
Brain Res. 2006 Jun 22;1096(1):30-9. doi: 10.1016/j.brainres.2006.04.072. Epub 2006 Jun 9.
9
Flow cytometry application for studies on adenosine A2A receptors expression.
Acta Pol Pharm. 2008 Jan-Feb;65(1):65-70.
10
The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery.热稳定化 G 蛋白偶联受体(StaRs)的特性及其在药物发现中的应用。
Neuropharmacology. 2011 Jan;60(1):36-44. doi: 10.1016/j.neuropharm.2010.07.001. Epub 2010 Jul 17.

引用本文的文献

1
Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone.(S)-美沙酮作为μ-阿片受体配体具有独特的药效学特性和较低的滥用倾向。
Mol Psychiatry. 2024 Mar;29(3):624-632. doi: 10.1038/s41380-023-02353-z. Epub 2023 Dec 25.
2
Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals.在野生型动物中多巴胺能传递的可逆光控。
Int J Mol Sci. 2022 Sep 4;23(17):10114. doi: 10.3390/ijms231710114.
3
Heterobivalent Ligand for the Adenosine A-Dopamine D Receptor Heteromer.双价配体与腺苷 A-多巴胺 D 受体异源二聚体。
J Med Chem. 2022 Jan 13;65(1):616-632. doi: 10.1021/acs.jmedchem.1c01763. Epub 2022 Jan 4.
4
Heteromerization between α adrenoceptors and different polymorphic variants of the dopamine D receptor determines pharmacological and functional differences. Implications for impulsive-control disorders.α肾上腺素能受体与多巴胺 D 受体的不同多态变体之间的异源二聚化决定了药理学和功能上的差异。对冲动控制障碍的影响。
Pharmacol Res. 2021 Aug;170:105745. doi: 10.1016/j.phrs.2021.105745. Epub 2021 Jun 26.
5
Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.重新解释 G 蛋白偶联受体同源二聚体中异常竞争结合实验,使用二聚体受体模型。
Pharmacol Res. 2019 Jan;139:337-347. doi: 10.1016/j.phrs.2018.11.032. Epub 2018 Nov 22.
6
Design of a True Bivalent Ligand with Picomolar Binding Affinity for a G Protein-Coupled Receptor Homodimer.设计一种具有皮摩尔亲和力的真正二价配体,用于与 G 蛋白偶联受体同源二聚体结合。
J Med Chem. 2018 Oct 25;61(20):9335-9346. doi: 10.1021/acs.jmedchem.8b01249. Epub 2018 Oct 11.
7
Overview of the detection methods for equilibrium dissociation constant of drug-receptor interaction.药物-受体相互作用平衡解离常数检测方法概述
J Pharm Anal. 2018 Jun;8(3):147-152. doi: 10.1016/j.jpha.2018.05.001. Epub 2018 May 5.
8
α- and α-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.α-和α-肾上腺素受体作为多巴胺和多巴胺受体配体的潜在靶点。
Mol Neurobiol. 2018 Nov;55(11):8438-8454. doi: 10.1007/s12035-018-1004-1. Epub 2018 Mar 18.
9
Molecular Evidence of Adenosine Deaminase Linking Adenosine A Receptor and CD26 Proteins.腺苷脱氨酶连接腺苷A受体与CD26蛋白的分子证据
Front Pharmacol. 2018 Feb 15;9:106. doi: 10.3389/fphar.2018.00106. eCollection 2018.
10
Heterogeneities in Axonal Structure and Transporter Distribution Lower Dopamine Reuptake Efficiency.轴突结构和转运体分布的异质性降低多巴胺再摄取效率。
eNeuro. 2018 Feb 5;5(1). doi: 10.1523/ENEURO.0298-17.2017. eCollection 2018 Jan-Feb.